INTEGRUM Aktie

 

Mölndal, Sweden, June 16, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has terminated the agreement with Redeye regarding equity research coverage. Redeye will continue to cover Integrum until the agreement expires on December 11, 2025. Integrum retains the commissioned research from DNB Carnegie: Integrum - Carnegie (https://www.carnegie.se/en/commissioned-research/integrum/)...

Mölndal, Sweden, June 16[th], 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Louise Wåhlin has been appointed new Chief Financial Officer. She will take on her new position on September 15[th] 2025. Louise Wåhlin has broad experience from senior finance roles at companies such as Getinge and Polestar and, most recently, as CFO for Capture Energy. Her education includes studies at the Gothenburg School of Economics. Louise is succeeding Jörgen Svanström, interim CFO, who will be available during the transition. "I welcome Louise Wåhlin to...

CHICAGO, June 2, 2025 /PRNewswire/ -- Stout, a leading global advisory firm, announced today that it has entered into a new strategic partnership with Integrum Holdings LP ("Integrum"), a private investment firm focused on partnering with technology-enabled services companies in the......

Mölndal, Sweden – May 30, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its fourth quarter 2024/25 results on June 3, 2025 at 14:00 CET. Integrum's CEO Martin Hillsten will present the report together with board member and former CEO Scott Flora and CFO Jörgen Svanström in a webcast. The presentation will be held in English. Time: Tuesday, June 3, 2025 at 14:00 CET. Location: Webcast (see link below). The report will be available at https://integrum.se/investor-relations/financial-reports-calendar/ The webcast and...

Mölndal, Sweden, May 21, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered a distribution agreement with Bionics Group Ukraine, LLC., a niche distributor-integrator of medical equipment for hospitals and private clinics in Ukraine. The agreement covers units that are used in the surgical implantation (S1 and S2 procedures) of the OPRA® Implant System. Integrum has been present in Ukraine since May 2023, when the first prosthetic procedures using the OPRA® Implant System were performed by Dr. Rickard Brånemark. In December 2023,...

Mölndal, Sweden, May 19, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered a commercial distribution agreement with Labormed d.o.o., a niche distributor-integrator of medical equipment for orthopaedic treatment clinics in Slovenia. The initial order covers the distribution of OPRA® Implant System units intended for thumb reconstruction surgeries. Integrum develops and sells OPRA® Implant System, the world's first prosthetic implant system to reconstruct whole limbs based on osseointegration. The initial order from Labormed...

MÖLNDAL, Sweden, May 5, 2025 /PRNewswire/ -- Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Martin Hillsten as the new CEO, effective immediately. He succeeds acting CEO Scott Flora, who will continue to support US marketing activities in......

MÖLNDAL, Sweden , March 28, 2025 /PRNewswire/ -- Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has implemented a new compensation package for its Board Director and Acting CEO Scott Flora. "Integrum is currently undergoing a major......

MÖLNDAL, Sweden, March 18, 2025 /PRNewswire/ -- Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that a newly published independent study from the Walter Reed National Military Medical Center in Bethesda, Maryland, U.S., provides compelling evidence of OPRA™......

Mölndal, Sweden, March 18, 2025 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that a newly published independent study from the Walter Reed National Military Medical Center in Bethesda, Maryland, U.S., provides compelling evidence of OPRA[TM] Implant System's treatment effectiveness in transfemoral amputees. The study demonstrates significant functional improvements over traditional socket prostheses, an important validation of Integrum's innovative technology and its clinical benefit in patients who have undergone amputation. The two-year follow-up study (...

Mölndal, Sweden – February 27, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its third quarter 2024/25 results on March 3, 2025 at 14:00 CET. Integrum's CEO Scott Flora will present the report together with CFO Jörgen Svanström in a webcast. The presentation will be held in English. Time: Monday, March 3, 2025 at 14:00 CET. Location: Webcast (see link below). The report will be available at https://integrum.se/investor-relations/financial-reports-calendar/ The webcast and presentation material will be accessible via https://...

MÖLNDAL, Sweden, Jan. 28, 2025 /PRNewswire/ -- Integrum, (STO: INTEG) , the leader in innovative bone-anchored prosthetic solutions, is proud to announce the expansion of their 2025 Education Calendar. In collaboration with Southern Prosthetic Supply (SPS), the leading U.S. distributor of......

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, welcomes the new board members Kristofer Westergren and Anette Lindqvist elected on the Extra General Meeting. Kristofer Westergren represents a group of major private shareholders in Integrum AB. He has followed the company closely for several years and thus has extensive knowledge of the business. "Integrum has a strong market position and a large untapped potential that, for various reasons, is not reflected in today's valuation. I look forward to an active...

MÖLNDAL, Sweden, Jan. 15, 2025 /PRNewswire/ -- Integrum AB (publ), ticker (STO: INTEG), the medical technology company that provides the bone-anchored OPRA® Implant System to amputees, partners with Intelerad to Streamline Surgical Planning and Enhance Patient Outcomes As part of its......

Integrum AB (publ), short name INTEG, the medical technology company that provides the bone-anchored OPRA™ Implant System to amputees, announces that the election committee of Integrum plans to propose the election of Anette Lindqvist as board member at an extra general meeting . Board member Patric Lindgren has informed the election committee that he has resigned from the board on December 18. Notice of the extraordinary general meeting will be issued shortly. Presentation of Anette Lindqvist Anette Lindqvist has a degree in business administration from Gothenburg School of Economics and...

Mölndal, Sweden – November 29, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its second quarter 2024/25 results on December 4, 2024 at 14:00 CEST. Integrum's CEO Scott Flora will present the report together with CFO Jörgen Svanström in a webcast. The presentation will be held in English. Time: Wednesday, December 4, 2024 at 14:00 CEST. Location: Webcast (see link below). The report will be available at https://integrum.se/investor-relations/financial-reports-calendar/ The webcast and presentation material will be accessible...

Integrum AB (publ), ticker INTEG, a leader in medical technology and developer of the bone-anchored OPRA® Implant System, announces the launch of a new service initiative to enhance warranty and service support for its Axor™ II devices. This initiative is a critical step in advancing Integrum's expansion in the U.S. market and driving sustainable growth. The new program focuses on significantly reducing service turnaround times and delivering a streamlined, efficient customer experience for Axor™ II devices in the U.S. With this initiative, Integrum aims to provide unmatched support to...

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees announces its education forum debut. Integrum's U.S. team recently exhibited at the Orthopedic Trauma Association (OTA) annual meeting, held last week in Montreal. Presented to attendees was a half-day educational forum titled “The Future is Now: Osseointegration for Amputation Reconstruction,” moderated by Dr. Joseph Hsu, one of Integrum's lead surgeons. This forum marked the first time an osseointegration symposium has been included in the OTA educational...

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, announces that Ty Hanners has been appointed Director of Sales, US, focused on expanding the OPRA surgical system product offering to amputees. He will start on October 14, 2024. Ty Hanners is a results-oriented sales leader with over 20 years in the prosthetic and orthopedic implant industry. He most recently served as a sales leader at Willowood Inc. and has past experience at Össur and Xtremity, innovative prosthetic and medical companies. Ty will be focused on...

Integrum AB (publ), the medical technology company that improves the lives of amputees, cordially invites you to an online investor information session on September 25, 2024, @ 3 pm CEST. This session will feature our acting CEO Scott Flora, and CFO, Jörgen Svanström, who will share insights into the company's strategic direction and upcoming initiatives. A warm welcome to join us to learn more about Integrum's next steps. When: 25 September 2024 @3pm-3.30pm Where: https://www.finwire.tv/webcast/integrum/integrum-meeting/ We look forward to seeing you online!...